MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-AS-09-0003981
Admiris Pharmaceuticals Private Limited
Admiris Pharmaceuticals Private Limited - chemicals in Dhubri, Assam, India. Directors, charges & compliance details.
Revenue · FY 2025
₹39.6 Lakh
▲ 80% YoY
Net profit · FY 2025
₹2.52 Lakh
Net margin 6.4%
EBITDA · FY 2025
₹4.05 Lakh
EBITDA margin 10.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹50,000
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Admiris Pharmaceuticals Private Limited
Data last updated:
Admiris Pharmaceuticals Private Limited is a private limited company based in Dhubri, Assam, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 21 April 2022.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24290AS2022PTC022850.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹50,000. It is led by directors including Pinki Rani Shaha and Bijay Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dhubri Ward No – 12, Assam, India – 783301.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.6 Lakh, a growth of 80% compared to the previous year. For the same year it recorded a net profit of ₹2.52 Lakh (net margin 6.4%) and EBITDA of ₹4.05 Lakh (EBITDA margin 10.2%).
Admiris Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-09-0003981).
Company details
CIN U24290AS2022PTC022850
Registration Number 022850
Incorporation Date 21 April 2022
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-AS-09-0003981
Recognitions & Rankings of Admiris Pharmaceuticals
Contact details
Admiris Pharmaceuticals Private Limited's registered office is in Dhubri, Assam.
- Registered AddressDhubri Ward No – 12, Assam, India – 783301
- IndustryChemicals, Other Chemical Product, Manufacturing
Comprehensive company report
Admiris Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Admiris Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Admiris Pharmaceuticals Private Limited, buy the company report.
Financials of Admiris Pharmaceuticals Private Limited
FY 2025 filings availableAdmiris Pharmaceuticals Private Limited reported revenue of ₹39.6 Lakh (up 80% YoY) for FY 2025.
Revenue · FY 2025
₹39.6 Lakh ▲ 80%
Net profit · FY 2025
₹2.52 Lakh margin 6.4%
EBITDA · FY 2025
₹4.05 Lakh margin 10.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 80%
EBITDA CAGR growth
1 year
▲ 89%
Revenue rose 80% in the latest year. EBITDA rose 89% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹4.05 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹2.52 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 10.2% | ||
| Net Profit Margin | 6.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Admiris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Admiris Pharmaceuticals Private Limited
Admiris Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pinki Rani Shaha Also directs: Admiris Healthcare Private Limited | Director | 21 Apr 2022 | 4 Years 6 Months | Current |
| Bijay Kumar Gupta | Director | 02 Apr 2024 | 2 Years 6 Months | Current |
| Anamika Saha | Director | 21 Apr 2022 | 4 Years 6 Months | Current |
| Priyanka Kumari | Director | 25 Mar 2025 | 1 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Admiris Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Admiris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Admiris Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Admiris Pharmaceuticals Private Limited has 7 board changes on record since 2022: 4 appointments and 3 cessations. The latest: Priyanka Kumari ceased to be Additional Director on 29 Sep 2025.
AGM
Admiris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Priyanka Kumari ceased to be Additional Director.
Filing
Admiris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Guwahati.
Appointed
Priyanka Kumari was appointed as Director.
Ceased
Bijay Kumar Gupta ceased to be Additional Director.
Appointed
Bijay Kumar Gupta was appointed as Director.
Ceased
Mampi Rani Paul Das ceased to be Director.
Appointed
Anamika Saha was appointed as Director.
Appointed
Pinki Rani Shaha was appointed as Director.
Incorporation
21 Apr 2022
Admiris Pharmaceuticals Private Limited was registered on 21 Apr 2022 with Roc Guwahati & aged 4 years 6 months as per MCA records.
Frequently asked questions
Admiris Pharmaceuticals is an active private limited company based in Dhubri, Assam, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 21 April 2022 (4+ years old) and is registered under CIN U24290AS2022PTC022850.
Admiris Pharmaceuticals has 4 current directors:
- Pinki Rani Shaha - Director
- Bijay Kumar Gupta - Director
- Anamika Saha - Director
- Priyanka Kumari - Director
The latest financial statements of Admiris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Admiris Pharmaceuticals is U24290AS2022PTC022850. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Admiris Pharmaceuticals was incorporated on 21 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Guwahati.
Priyanka Kumari ceased to be Additional Director on 29 Sep 2025. Priyanka Kumari was appointed as Director on 25 Mar 2025. Bijay Kumar Gupta ceased to be Additional Director on 28 Jun 2024. Admiris Pharmaceuticals has 7 board changes on record in total.
Yes, Admiris Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-AS-09-0003981).
The registered office of Admiris Pharmaceuticals is at Dhubri Ward No – 12, Assam, India – 783301.
Admiris Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.
Admiris Pharmaceuticals can be reached at its registered office: Dhubri Ward No – 12, Assam, India – 783301.